Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Susette Audet"'
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220780 (2019)
Measles virus is highly infectious and remains a leading cause of vaccine preventable deaths in children. Neutralizing antibody responses elicited by measles virus infection or immunization are a serological correlate of protection. We describe a hig
Externí odkaz:
https://doaj.org/article/c574039d78554e6a875b20e7cb108dd4
Autor:
Roberta Lynne Crim, Sangeeta Kumari, Priyanka Jayanti, Susette Audet, Ashwin Kulkarni, Judy Beeler
Publikováno v:
Vaccines, Vol 7, Iss 1, p 16 (2019)
Respiratory syncytial virus (RSV) causes severe lower respiratory tract disease in infants and the elderly. Although there is no licensed vaccine, RSV-F and -G glycoproteins are targets for vaccine development and therapeutics. We developed an assay
Externí odkaz:
https://doaj.org/article/8b8b134b96934f85a0cad444307a428f
Autor:
Susette Audet, Linda L. Yasukawa, Judy A. Beeler, Tobias R. Kollmann, Laura Gelinas, Hayley A. Gans, Stuart E. Turvey, Cathleen A. Collins, Bahaa Abu-Raya
Publikováno v:
J Pediatric Infect Dis Soc
In this study, we illustrate, for the first time, that preexisting low-avidity neutralizing measles maternal antibodies do not interfere with the development of high concentrations of high-avidity measles antibodies in children immunized at age 12 mo
Autor:
Jessica Mooney, Judy A. Beeler, Lei Zhang, Susette Audet, Maria Rosario Capeding, Kathleen M. Neuzil, Damon W. Ellison, Jodi Feser, Edison Alberto, Yuxiao Tang, G. William Letson, Anthony A. Marfin
Publikováno v:
Vaccine: X
Vaccine: X, Vol 6, Iss, Pp 100074-(2020)
Vaccine: X, Vol 6, Iss, Pp 100074-(2020)
Highlights • Live, attenuated SA 14-14-2 JE vaccine is immunogenic when given with MMR vaccine. • Live, attenuated SA 14-14-2 JE vaccine is safe when given with MMR vaccine. • Live, attenuated SA 14-14-2 JE vaccine may be coadministered with MM
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220780 (2019)
PLoS ONE
PLoS ONE
Measles virus is highly infectious and remains a leading cause of vaccine preventable deaths in children. Neutralizing antibody responses elicited by measles virus infection or immunization are a serological correlate of protection. We describe a hig
Autor:
Ashley Fowlkes, Felicity T. Cutts, Judy A. Beeler, Rita F. Helfand, Susette Audet, William J. Bellini, Desiree Witte, Robin L. Broadhead
Publikováno v:
Vaccine
Background The long-term antibody response to measles vaccine (MV) administered at age 6 months with or without subsequent doses is not well documented. Methods Measles serum antibody responses were evaluated after a supplemental dose of measles vacc
Autor:
Sandra K. Freeman, Marcia McGrew, Rupak Shivakoti, Edward A. Belongia, Laura A. Coleman, Carole J. Hickman, Ashwin Kulkarni, Sara Mercader, Amy Parker Fiebelkorn, Diane E. Griffin, William J. Bellini, Daoling Bi, Daphne York, Susette Audet, Judith Beeler
Publikováno v:
Journal of Infectious Diseases. 213:1115-1123
BACKGROUND Two doses of measles, mumps, and rubella (MMR) vaccine are 97% effective against measles, but waning antibody immunity to measles and failure of the 2-dose vaccine occur. We administered a third MMR dose (MMR3) to young adults and assessed
Autor:
Haruhiko Murata, Susette Audet, Roberta Lynne Crim, Thembi Mdluli, Judy A. Beeler, Sangeeta Kumari, Ashwin Kulkarni
Publikováno v:
Clinical and Vaccine Immunology. 21:383-390
The nucleoprotein of respiratory syncytial virus (RSV-N) is immunogenic and elicits an IgG response following infection. The RSV-N gene was cloned into a mammalian expression vector, pREN2, and the expressed luciferase-tagged protein (Ruc-N) detected
Autor:
Susette Audet, Roberta Lynne Crim, Ashwin Kulkarni, Sangeeta Kumari, Judy Beeler, Priyanka Jayanti
Publikováno v:
Vaccines, Vol 7, Iss 1, p 16 (2019)
Vaccines
Volume 7
Issue 1
Vaccines
Volume 7
Issue 1
Respiratory syncytial virus (RSV) causes severe lower respiratory tract disease in infants and the elderly. Although there is no licensed vaccine, RSV-F and -G glycoproteins are targets for vaccine development and therapeutics. We developed an assay
Autor:
Min Qin, Myron J. Levin, Sun Bae Sowers, P s Protocol Teams, Mark J. Abzug, William Borkowsky, Sharon Nachman, Susette Audet, Stephen I. Pelton, William J. Bellini, Howard M. Rosenblatt, Terence Fenton, Judy A. Beeler
Publikováno v:
Journal of Infectious Diseases. 206:512-522
Background. Response rates and immunologic memory following measles vaccination are reduced in human immunodeficiency virus (HIV)–infected children in the absence of highly active antiretroviral therapy (HAART). Methods. HIV-infected children 2 to